Dr. Timothy Dorius
Claim this profileNebraska Methodist Hospital
Studies Lung Cancer
Studies Cancer
9 reported clinical trials
22 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
More about Timothy Dorius
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Timothy Dorius has experience with
- Carboplatin
- Atezolizumab
- Etoposide
- Durvalumab
- Crofelemer
- Docetaxel
Breakdown of trials Timothy Dorius has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy Dorius specialize in?
Timothy Dorius focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Timothy Dorius currently recruiting for clinical trials?
No, Timothy Dorius is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Timothy Dorius has studied deeply?
Yes, Timothy Dorius has studied treatments such as Carboplatin, Atezolizumab, Etoposide.
What is the best way to schedule an appointment with Timothy Dorius?
Apply for one of the trials that Timothy Dorius is conducting.
What is the office address of Timothy Dorius?
The office of Timothy Dorius is located at: Nebraska Methodist Hospital, Omaha, Nebraska 68114 United States. This is the address for their practice at the Nebraska Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.